Afcus Pharmaceuticals (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-05-2024
- Paid Up Capital ₹ 0.10 M
as on 22-05-2024
- Company Age 3 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
About Afcus Pharmaceuticals (Opc)
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akhlaque Khan serves as a director at the Company.
- CIN/LLPIN
U24303CH2021OPC044090
- Company No.
044090
- Incorporation Date
14 Dec 2021
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Afcus Pharmaceuticals (Opc) Private Limited offer?
Afcus Pharmaceuticals (Opc) Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharma & Bioanalytical Services, PCD Pharma Franchise, Antacid Drugs, Antibiotic Injection.
Who are the key members and board of directors at Afcus Pharmaceuticals (Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akhlaque Khan  | Director | 14-Dec-2021 | Current |
Financial Performance of Afcus Pharmaceuticals (Opc).
Enhance accessibility to Afcus Pharmaceuticals (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Afcus Pharmaceuticals (Opc)?
Unlock access to Afcus Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Afcus Pharmaceuticals (Opc)?
Afcus Pharmaceuticals (Opc) has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Afcus Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Afcus Pharmaceuticals (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
